While aspirin is traditionally the standard antiplatelet agent, recent studies suggest that P2Y12 inhibitors, such as clopidogrel, may be more effective for long-term secondary prevention.

"Triple therapy" with aspirin, clopidogrel, and warfarin has become an increasingly common clinical scenario in the drug-eluting stent era. While there is general acceptance that multiagent ...

After endoscopic documentation of ulcer healing, patients received either clopidogrel (75 mg daily) plus placebo or aspirin (80 mg daily) plus esomeprazole (20 mg twice daily). Patients who tested ...

For decades, aspirin has been the standard preventive treatment for patients with blood vessel disease. After an acute ...

You may need to read it again. PIAX PLUS ASPIRIN 75/100 contains the medicines clopidogrel and aspirin. PIAX PLUS ASPIRIN 75/100 belongs to a group of medicines called anti-platelet medicines ...